ESR1 and breast cancer: Co-delivery of palbociclib with ultra-small magnesium nanoclusters was found to be more effective than free palbociclib at inhibiting cell growth in cytotoxicity assays conducted on estrogen receptor and folate receptor-positive breast cancer cells.